Worth Seeing!
Invest in Cases Systematically - Every stock is handpicked Start Buying Now Start Buying Now
mw4me logo
Talk to Us | Subscribe | Advisory Services

Top Pharma Companies in India by Market Capitalisation - Identify Top Performing Pharmaceutical Sector Companies for Investment Today

Sensex 72404.17
1062.22 (-1.45%)

Pharma Sector Overview

Presently, India is the largest provider of generic medicines, occupying a market share of 20 percent with respect to global supply by volume and fulfils nearly 60 percent of global demand for vaccines. Indian pharmaceutical stocks even supply nearly 80 percent of antiretroviral drugs (used in combating AIDS) in the international markets.
There are several benefits of investing in pharma stocks:
  • Long-term profitability – Pharma stocks can be attractive to long-term investors in spite of the volatility. The ever rising industry size and healthcare becoming a critical part of life, investors can make good returns if they invest at the right time.
  • Exponential growth – Being the evolving industry that it is, innovation, scientific breakthroughs, and technological advances can bring in exponential growth for many pharma stocks.
×
×
Filter

Top Pharma Companies in India as on May-2024

|
 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Filter
Company Name
Market cap
(Rs. Cr.)
CMP
(Change %)
Latest
P/E
Latest
P/BV
5Y Sales
Gr.(%)
5Y Profit
Gr.(%)
DeciZen
More Info
1
Sun Pharma Advanced Research Company Ltd.
7,154
(Small Cap)
212.50
(-3.61%)
N/A
29.72
24.99
0.00
Q V+ PT
2
Glaxosmithkline Pharmaceuticals Ltd.
34,100
(Mid Cap)
1,983.65
(-1.45%)
63.19
21.08
2.52
11.21
Q V+ PT
3
Sanofi India Ltd.
18,989
(Small Cap)
8,082
(-1.98%)
30.9
19.68
0.57
9.48
Q V+ PT
4
Astrazeneca Pharma India Ltd.
13,278
(Small Cap)
5,110.60
(-3.78%)
92.11
19.13
11.93
36.87
Q V+ PT
5
Abbott India Ltd.
55,133
(Mid Cap)
25,606.55
(-1.31%)
47.41
15.88
10.15
20.60
Q V+ PT
6
Gujarat Themis Biosyn Ltd.
2,975
(Small Cap)
400
(-2.33%)
52.35
15.06
30.87
72.01
Q V+ PT
7
Global Health Ltd.
38,006
(Mid Cap)
1,400
(-1.09%)
107.24
13.6
7.84
44.84
Q V+ PT
8
Torrent Pharmaceuticals Ltd.
87,583
(Large Cap)
2,520
(-2.62%)
57.13
11.94
10.09
20.94
Q V+ PT
9
Rainbow Childrens Medicare Ltd.
13,743
(Small Cap)
1,408
(3.99%)
64.62
11.57
22.62
38.74
Q V+ PT
10
Vijaya Diagnostic Centre Ltd.
6,961
(Small Cap)
731.65
(7.75%)
63.12
11.41
0.00
0.00
Q V+ PT
11
Apollo Hospitals Enterprise Ltd.
84,045
(Large Cap)
5,805.90
(-0.67%)
83.63
11.05
-1.90
34.75
Q V+ PT
12
Poly Medicure Ltd.
15,418
(Small Cap)
1,591.70
(-0.92%)
63.89
11
16.00
20.25
Q V+ PT
13
Concord Biotech Ltd.
16,225
(Small Cap)
1,504.40
(-3.00%)
65.45
11
0.00
0.00
Q V PT
14
Dr. Lal Pathlabs Ltd.
19,451
(Small Cap)
2,240.45
(-3.85%)
50.8
9.8
11.55
11.64
Q V PT
15
JB Chemicals & Pharmaceuticals Ltd.
27,838
(Small Cap)
1,762.55
(-1.74%)
54.12
9.74
18.11
31.92
Q V+ PT
16
Max Healthcare Institute Ltd.
78,098
(Mid Cap)
793.55
(-1.24%)
73.12
9.5
21.42
0.00
Q V+ PT
17
Mankind Pharma Ltd.
87,328
(Large Cap)
2,212
(1.47%)
52.62
9.48
15.71
13.53
Q V PT
18
Narayana Hrudayalaya Ltd.
25,973
(Small Cap)
1,247
(-1.88%)
32.92
9.44
14.68
62.83
Q V+ PT
19
Procter & Gamble Health Ltd.
7,878
(Small Cap)
4,648.45
(-2.06%)
36.15
9.08
11.99
36.80
Q V PT
20
Krishna Institute of Medical Sciences Ltd
16,169
(Small Cap)
1,993.35
(-1.34%)
61.17
8.81
12.50
0.00
Q V PT
21
Ajanta Pharma Ltd.
29,804
(Mid Cap)
2,410.05
(1.82%)
37.18
8.51
11.98
4.54
Q V PT
22
Suven Pharmaceuticals Ltd.
16,688
(Small Cap)
653.60
(-0.30%)
44.31
8.29
0.00
0.00
Q V PT
23
Metropolis Healthcare Ltd.
9,036
(Small Cap)
1,721
(-2.43%)
70.63
8.21
12.15
6.00
Q V PT
24
Divis Laboratories Ltd.
1,04,300
(Large Cap)
3,784
(-3.69%)
72.74
7.72
14.82
15.00
Q V PT
25
Neuland Laboratories Ltd.
9,555
(Small Cap)
7,212.25
(-3.16%)
28.96
7.59
17.70
56.85
Q V+ PT
26
Advanced Enzyme Technologies Ltd.
4,391
(Small Cap)
386.30
(-1.62%)
35.24
7.51
8.00
9.23
Q V PT
27
Artemis Medicare Services Ltd.
2,569
(Small Cap)
187.35
(-0.16%)
57.99
7.16
7.28
17.28
Q V+ PT
28
AMI Organics Ltd.
4,445
(Small Cap)
1,205
(-0.01%)
113.43
6.85
26.79
33.72
Q V PT
29
Jupiter Life Line Hospitals Ltd.
8,185
(Small Cap)
1,218
(-2.43%)
74.71
6.66
19.71
26.72
Q V PT
30
Thyrocare Technologies Ltd.
3,264
(Small Cap)
629.95
(2.19%)
50.24
6.58
8.13
-7.14
Q V PT
Prev 1

Want to pick best stocks Undervalued Pharma Stocks for High returns?

Check Now!
Screens:
AlphaCases All-Weather Stocks 5 Star Rated Stocks Best Nifty 50 Stocks Best Nifty Next 50 Stocks Best Nifty 500 Stocks Best SmallCap Stocks Dividend Opp. Stocks Nifty Financial Services Stocks
×
×

Pharma - Today's Top Gainers

Company Name CMP Price Change(%)
Vijaya Diagnostic
731.657.75%
RainbowChildrenS Med
1,4083.99%
Thyrocare Tech.
629.952.19%
Ajanta Pharma
2,410.051.82%
Mankind Pharma
2,2121.47%
View More

Pharma - Today's Top Losers

Company Name CMP Price Change(%)
Suven Life Sciences
99.50-4.92%
Granules India
393.40-4.28%
Dishman Carbogen Amc
198.80-4.12%
Jagsonpal Pharma
323.05-3.85%
Dr. Lal Pathlabs
2,240.45-3.85%
View More

News about Top Pharma Companies in India

Vijaya Diagnostic - Quaterly Results

A fair growth of 19.20% in the revenue at Rs. 1410.52 millions was reported in the March 2024 quarter as compared to Rs. 1183.33 millions during year-ago period.A slim rise of 13.32% was recorded in the Net profit for the quarter ended March 2024 to Rs. 305.09  millions  From Rs. 269.24 millions.Operating Profit saw a handsome growth to 606.57 millions from 526.22 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1410.52 1183.33 19.20 5250.23 4495.79 16.78 5250.23 4495.79 16.78
Other Income 34.06 45.30 -24.81 214.39 145.73 47.11 214.39 145.73 47.11
PBIDT 606.57 526.22 15.27 2336.36 1935.44 20.71 2336.36 1935.44 20.71
Interest 59.48 57.58 3.30 237.08 208.76 13.57 237.08 208.76 13.57
PBDT 547.09 468.64 16.74 2078.78 1726.68 20.39 2078.78 1726.68 20.39
Depreciation 149.07 113.20 31.69 554.06 613.94 -9.75 554.06 613.94 -9.75
PBT 398.02 355.44 11.98 1524.72 1112.74 37.02 1524.72 1112.74 37.02
TAX 92.93 86.20 7.81 378.70 280.39 35.06 378.70 280.39 35.06
Deferred Tax 19.83 8.01 147.57 57.70 5.09 1033.60 57.70 5.09 1033.60
PAT 305.09 269.24 13.32 1146.02 832.35 37.68 1146.02 832.35 37.68
Equity 102.35 102.07 0.27 102.35 102.07 0.27 102.35 102.07 0.27
PBIDTM(%) 43.00 44.47 -3.30 44.50 43.05 3.37 44.50 43.05 3.37
08 May, 2024

GlaxoSmithKline Pharmaceuticals informs about loss of share certificate

Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Regulations’), GlaxoSmithKline Pharmaceuticals has informed that Registrar and Transfer Agent of Company - KFin Technologies has received request for issue of duplicate Share Certificates from Shareholders, Hemant Kumar Bhansaly & Meena Poladia further details enclosed. The company will issue the Letter of Confirmation only after the necessary formalities are carried out by the Shareholders.

The above information is a part of company’s filings submitted to BSE.

08 May, 2024

GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificate

 Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Regulations’), GlaxoSmithKline Pharmaceuticals has informed that Registrar and Transfer Agent of Company - KFin Technologies has received request for issue of duplicate Share Certificates from Shareholder, as details enclosed. The company shall issue the Letter of Confirmation only after the necessary formalities are carried out by the Shareholder.

The above information is a part of company’s filings submitted to BSE.


07 May, 2024

AstraZeneca Pharma India informs about certificate

AstraZeneca Pharma India has informed that it enclosed the Certificate dated May 2, 2024 issued by Integrated Registry Management Services, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

The above information is a part of company’s filings submitted to BSE.

03 May, 2024

AstraZeneca Pharma India informs about certificate

AstraZeneca Pharma India has informed that it enclosed Certificate dated May 2, 2024 issued by Integrated Registry Management Services, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

The above information is a part of company’s filings submitted to BSE.

03 May, 2024

Dr. Lal PathLabs informs about board meeting

Dr. Lal PathLabs has informed that a meeting of the Board of Directors is scheduled to be held on Friday, May 10, 2024 to consider and approve the Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Financial year ended March 31, 2024 and to consider recommending Final Dividend, if any, on the Equity Shares of the Company for the Financial Year ended March 31, 2024. Further, in continuation to its letter dated March 26, 2024 and in line with the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's code for Prevention of Insider Trading, the Trading Window for dealing in Securities of the Company is closed and shall re-open after 48 hours from the declaration of the aforesaid Financial Results.

The above information is a part of company’s filings submitted to BSE.

03 May, 2024

Track Now: 5 Star Companies, Large Cap Companies, Mid Cap Companies, Small Cap Companies, Nifty Microcap Companies, Top IT Companies, Tax saver funds, Analyze your Equity Funds, Nifty Index Funds

Trending on MoneyWorks4Me: Stock Reasearch Reports, How many stocks to own in portfolio?, Why PE Ratio is important?, How to Choose Good Stocks?, Types of Mutual Funds, Why funds future upside is more useful than past performance?

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2024.
Rank Company Market Capitalization 2024 (INR  crores)
1 Sun Pharma Advanced Research Company Ltd. 7,154 Crore
2 Glaxosmithkline Pharmaceuticals Ltd. 34,100 Crore
3 Sanofi India Ltd. 18,989 Crore
4 Astrazeneca Pharma India Ltd. 13,278 Crore
5 Abbott India Ltd. 55,133 Crore
6 Gujarat Themis Biosyn Ltd. 2,975 Crore
7 Global Health Ltd. 38,006 Crore
8 Torrent Pharmaceuticals Ltd. 87,583 Crore
9 Rainbow Childrens Medicare Ltd. 13,743 Crore
10 Vijaya Diagnostic Centre Ltd. 6,961 Crore
Find best pharma stocks to buy now
Do you know?
Asking 3 Right Questions minimizes the
RISK of Stock Investing
To Know
Right Stock | Right Price | Right Allocation
Find best stocks to buy now

Top Pharma Companies FAQs Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Sanofi India Ltd. (S) Very Good 8,082 18,989 31.48 20.05 21.38 51.69
Abbott India Ltd. (M) Very Good 25,607 55,133 48.13 16.12 32.82 31.69
Laurus Labs Ltd. (S) Very Good 427.1 23,399 145.7 5.69 32.05 21.71
Dr. Reddys Laboratories Ltd. (L) Very Good 5,879 1,01,035 18.11 3.58 11.44 20.88
Torrent Pharmaceuticals Ltd. (L) Very Good 2,520 87,583 58.62 12.25 28.15 20.23

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Lupin Ltd. (M) Somewhat Good 1,586 73,640 112.4
Zydus Lifesciences Ltd. (L) Very Good 967.8 1,01,202 84.45
Ipca Laboratories Ltd. (M) Very Good 1,283 33,429 83.38
Aurobindo Pharma Ltd. (M) Very Good 1,118 66,563 81.31
Glenmark Pharmaceuticals Ltd. (S) Somewhat Good 1,001 28,804 78.67
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Laurus Labs Ltd. (S) Very Good 427.1 23,399 145.7 5.69 32.05 24.05
Granules India Ltd. (S) Somewhat Good 393.4 9,961 21.47 3.31 13.02 19.01
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,763 27,838 55.00 9.90 32.50 18.11
Gland Pharma Ltd. (M) Very Good 1,691 28,263 35.28 3.26 20.05 17.42
Mankind Pharma Ltd. (L) Very Good 2,212 87,328 52.92 9.54 36.54 15.71

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Laurus Labs Ltd. (S) Very Good 427.1 23,399 145.7 5.69 32.05 38.61
Dr. Reddys Laboratories Ltd. (L) Very Good 5,879 1,01,035 18.11 3.58 11.44 36.08
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,763 27,838 55.00 9.90 32.50 31.92
Biocon Ltd. (M) Somewhat Good 298.9 36,810 19.21 3.38 99.09 31.80
Granules India Ltd. (S) Somewhat Good 393.4 9,961 21.47 3.31 13.02 31.51
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
SEBI Registered: Investment Adviser - INA000013323
Warning: Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer: Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provides any assurance of returns to investors.
Compliance Officer:
Name: Shrikant Jagtap
Email : shrikant.jagtap@moneyworks4me.com
Mobile No: +91 97638 00745
Grievance officer:
Name: Mukta Vaze
Email : mukta.vaze@moneyworks4me.com
Mobile No:+91 98609 19463
Principal Officer:
Name: Atharva Bhide
Email : atharva.bhide@moneyworks4me.com
Mobile No:+91 91758 99463
Sitemap play-store Download APP play-store Download APP
linkedin facebook twitter youtube insta telegram
Address: MoneyWorks4Me Investment Advisers, B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Register a Complaint | Complaint status | Cancellation and Refund Policy | PML Act | Grievance Redressal Process | Investor charter | Terms & Conditions | Disclaimer | Disclosure
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.